TD Asset Management’s Orchestra BioMed OBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Hold |
92,678
| – | – | ﹤0.01% | 1171 |
|
|
2025
Q1 | $397K | Hold |
92,678
| – | – | ﹤0.01% | 1167 |
|
|
2024
Q4 | $371K | Hold |
92,678
| – | – | ﹤0.01% | 1197 |
|
|
2024
Q3 | $465K | Hold |
92,678
| – | – | ﹤0.01% | 1309 |
|
|
2024
Q2 | $755K | Hold |
92,678
| – | – | ﹤0.01% | 1209 |
|
|
2024
Q1 | $488K | Hold |
92,678
| – | – | ﹤0.01% | 1299 |
|
|
2023
Q4 | $846K | Hold |
92,678
| – | – | ﹤0.01% | 1211 |
|
|
2023
Q3 | $808K | Buy |
92,678
+46,339
| +100% | +$404K | ﹤0.01% | 1181 |
|
|
2023
Q2 | $324K | Hold |
46,339
| – | – | ﹤0.01% | 1330 |
|
|
2023
Q1 | $907K | Hold |
46,339
| – | – | ﹤0.01% | 1150 |
|
|
2022
Q4 | $463K | Hold |
46,339
| – | – | ﹤0.01% | 1298 |
|
|
2022
Q3 | $459K | Hold |
46,339
| – | – | ﹤0.01% | 1311 |
|
|
2022
Q2 | $462K | Hold |
46,339
| – | – | ﹤0.01% | 1301 |
|
|
2022
Q1 | $459K | Hold |
46,339
| – | – | ﹤0.01% | 1350 |
|
|
2021
Q4 | $463K | Hold |
46,339
| – | – | ﹤0.01% | 1394 |
|
|
2021
Q3 | $458K | Hold |
46,339
| – | – | ﹤0.01% | 1403 |
|
|
2021
Q2 | $459K | Hold |
46,339
| – | – | ﹤0.01% | 1395 |
|
|
2021
Q1 | $520K | Hold |
46,339
| – | – | ﹤0.01% | 1390 |
|
|
2020
Q4 | $594K | Buy |
+46,339
| New | +$594K | ﹤0.01% | 1301 |
|